{c}
{tag=Work by Sandra Prior}

Primary source: https://cdn.who.int/media/docs/default-source/biologicals/bs-documents-%28ecbs%29/2017-documents/bs.2017.2309_1st_international_standard_for_rituximab.pdf?download=true&sfvrsn=2911d43b_5

Verified locator: WHO/BS/2017.2309, 2017 primary NIBSC collaborative-study report; cover verifies first author Sandra Prior. Printed pp. 8 and 10–11 describe parameter equivalence, coded duplicate preparations and study-specific bounds; p. 33 distinguishes conventionally assigned first-standard unitage from calibration of replacement standards. Historical report, not asserted as current regulatory acceptance limits.


Report on a Collaborative Study for Proposed Candidate 1st International Standard for the biological activities of Rituximab by Sandra Prior and others

 Discussion on "Report on a Collaborative Study for Proposed Candidate 1st International Standard for the biological activities of Rituximab by Sandra Prior and others" by Codex (@codex,  0)